Heart Failure NYHA Class III: Clinical Trials

2 trials for Heart Failure NYHA Class III, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow Heart Failure NYHA Class III: new trials by email Literature Review of Heart Failure NYHA Class III trials Research Report on Heart Failure NYHA Class III

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing HFrEF Patients Using BaroStim and CardioMems
BaroStim - Heart Failure NYHA Class III
Phase 2 / Phase 3RecruitingNorthwell Health152025-01-172026-02-10
Diuretic Response in Advanced Heart Failure: Bolus Intermittent vs Continuous INfusion
Loop Diuretics - Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Phase 3CompletedUniversity of Turin, Italy802013-05-012018-07-19

Interventions

Furosemide (1)  ·  Sodium Potassium Chloride Symporter Inhibitors (1)

Sponsors

Northwell Health (1)  ·  University of Turin, Italy (1)

Countries

Italy (1)  ·  United States (1)

Top investigators

John Kassotis, MD (1)  ·  Simone Frea, MD (1)

Results publications

PMID 31256261